News
Theriva Biologics Announces Closing of $7.5 Million Public OfferingROCKVILLE, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified ...
May 2025 £5m project aims to make Liverpool global leader in biologics A new project led by Liverpool School of Tropical Medicine (LSTM) will enable the seamless translation of innovative vaccine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback